Figure 4
Results of MSP in 48 HCC cases. (a) Methylation status in 48 primary HCC samples. Forty-one of 48 (85.4%) cancer tissues showed hypermethylation of DCDC2, while only 9 of 48 (18.7%) cases showed hypermethylation in adjacent normal tissues. (b) Four representative cases showing hypermethylation of the promoter region of DCDC2 in tumor tissues without methylation in normal tissues.
